The market reaction to the Medison news and the FDA announcement has been a big resounding "meh".

Thanks to this news I learned the Israel/Palestine populations.  And compared to the HL USA deal, its a bargain.  Israel/Palestine is roughly 4% of the US population....4% of $8 million is $320,000.....

Canada's population is roughly 3x that of Israel/Palestine.  Does that mean Resverlogix will negotiate a licensing deal in Canada for 3x the $0 up front payment from Medison?